medigraphic.com
ISSN 0016-3813 (Impreso)

2002, Número S1

<< Anterior Siguiente >>

Gac Med Mex 2002; 138 (S1)


Avances en medicina transfusional

I. Introducción
II. Del Banco de Sangre a la medicina transfusional
III. Experiencia del trasplante de células hematopoyéticas de sangre periférica en el Banco Central de Sangre, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social
IV. Estructura para crear un banco de tejidos
V. Inmunomodulación en transfusión sanguínea ¿realidad o ficción?

Malagón-MA, Marín-López A, Ambriz-Fernández R, Torradadella M, Duque-Rodríguez J

Idioma: Español
Referencias bibliográficas: 42
Paginas: 26-34
Archivo PDF: 150.74 Kb.


FRAGMENTO

El desarrollo de la medicina transfusional en lo referente a la producción de componentes sanguíneos se puede definir en cuatro generaciones como atinadamente lo ha descrito Mc. Cullough a través de los años.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Starr D. Blood: an epic history of medicine and commerce 1st ed. New York: Knopf; 1998.

  2. Cruz JR. Medicina transfusional en Hispanoamérica. Programa de medicamentos esenciales y tecnología. División de Desarrollo de Sistemas y Servicios de Salud. Organización Panamericana de la Salud. Annual PAHO Conference, Puerto Rico.

  3. Diario Oficial de la Federación, Estados Unidos Mexicanos. Mayo 27, 1987;1:28-36.

  4. Marín A. Prevalencia de anticuerpos contra el virus de la inmunodeficiencia del humano (VIH) y otros marcadores de enfermedades infecciosas en donadores remunerados de la Ciudad de Puebla. Rev Invest Clin 1987;39:219-22.

  5. Sepúlveda JA, García, LG, Domínguez T, Valdespino JL.Prevention of HIV transmission through blood and blood products: experience in Mexico. Bull Pan Am Health Organ 1989;23:108-14.

  6. Avila C, Stetler H, Sepúlveda J, et al. The epidemiology of HIV transmission among paid donors, Mexico City, Mexico. AIDS 1989; 3:631-3.

  7. Sepúlveda JA, del Rió AZ, et al. La estrategia de prevención de la transmisión del VIH/SIDA a través de la sangre y sus derivados en México. Salud Publica Mex 1995;37:624-35.

  8. Volkow P, Mohar A, et al. Changing risk factors for HIV infection in Mexican women. Arch Med Res 2001 (In press).

  9. World Health Day 2000: Information for National Blood Programmes. WHO Last Update September 2000.www-nt.who.int/world-health-day/en/gen/gen-fill.cfm?navid=68.

  10. Klein HG. Transfusion medicine: the evolution of a new discipline. JAMA 1987;258:2108-2109.

  11. Popovsky MA, Triulzi D. The role of the transfusion medicine consultant. Am J Clin Pathol 1996;105:798-801.

  12. Sánchez GS. El banco de sangre como servicio de interconsulta. Rev Invest Clin 1995;47:405-408.

  13. McCullough J. Blood bank and stem cell transplantation. Arch Pathol Lab Med 1991;115:12,1195-2000.

  14. Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood 1997; 89:7,2233-2258.

  15. Watts MJ. Linch D C. Peripheral blood stem cell transplantation. Vox Sang1997;73:3,135-142.

  16. Sweeney JD, Kouttab NM, et al. A comparison of prestorage WBC-reduced whole-blood-derived platelets and bedside-filtered whole-blood-derived platelets in autologous progenitor cell transplant. Transfusion 2000;40:7;794-800.

  17. Ramsey G, LA, Sherman LA. The new age of organic blood banking. Transfusion 1998; 38:1,9-11.

  18. Regulación del uso clínico de tejidos humanos. Real Decreto 411/1996, del 1 de marzo.

  19. Estándares de calidad del Banco de Tejidos. Asociación Española de bancos de tejidos (AEBT). 2nd ed.; 2000.

  20. A Code of practice for tissue banks, providing tissues of human origin for therapeutic purposes. Department of Health, UK; 1994.

  21. Standards for Tissue Banking. American Association of Tissue Banks (AATB). 1996. Library of Congress Catalog Card Number: 84-7269. USA.

  22. Friedenstein AJ, Chailakthian UV, Gerasimov UV. Cell Tissue Kinet 1987;20: 263.

  23. Vogel G. Can old cells learn new tricks? Science 2000;287: 1418-1419.

  24. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71-74.

  25. Abbas AK, Lichtman AH, JS. Pober. Cellular and molecular immunology. 3rd ed. Philadelphia, PA, USA: W.B. Saunders, 1997.

  26. Opelz G, Sengar M, et al. Effect of blood transfusions on subsequent kidney transplant. Transplant Proc 1973;5253-259.

  27. Heiss M, Mempel C. et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859-1867.

  28. Houbiers JG, Van de Velde L, et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 1997; 37:126-134.

  29. Peters W, Fry J, et al. Multiple blood transfusions reduce the recurrence rate of Crohn’s disease. Dis Colon Rectum 1989; 32:749-753.

  30. Sloand E, Kumar H, et al. Transfusion of blood components to persons infected with human immunodeficiency virus type 1: relationship to opportunistic infection. Transfusion 1994;34:48-53.

  31. Von Fliedner, et al. Graft-versus-host reaction following blood product transfusion. Am J Med 1982;72:951.

  32. Heddle N, Klama L, Griffith L, et al. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993;33:794.

  33. Wood, M, Gottschalk R, Monaco A. Effect of blood transfusion on IL-2 production. Transplantation 1988;45:930-935.

  34. Dharam P. Immunological Effects of blood transfusion. CRC Press Library; 1994.

  35. Opelz G, Terasaki P. Importance of preoperative (not perioperative) transfusion for cadaveric kidney transplant. Transplantation 1981; B1-106.

  36. Opelz G, Vanrenterghem Y, Kirste G, et al. Prospective evaluation of pretransplant blood transfusion in cadaver kidney recipients. Transplantation 1997;63: 964.

  37. Lagaaij E, Hennemann P, Ruigrok M, et al. Effect of one HLA-DR antigen matched and completely HLA-DR mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989; 321:701.

  38. Vamvakas E, Moore S. Blood transfusion and postoperative septic complications. Transfusion 1994; 34:714.

  39. Heiss M, Mempel W, Delanoff C, et al. Blood transfusion modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859.

  40. Vamvakas EC , Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001;97:1180.

  41. Kirkley AS. Proposed mechanisms of induced immunomodulation clinical and diagnostic laboratory immunology 1999;6:652.

  42. Stites PD. Inmunologia básica clínica .10th ed. México: Manual Moderno; 2000.




2020     |     www.medigraphic.com